LG expands B2B medical device lineup with FDA-cleared diagnostic monitor
LG Electronics has launched a new diagnostic monitor cleared by the U.S. Food and Drug Administration (FDA) as a medical device, expanding its lineup of business-to-business (B2B) displays for hospitals and clinics, the company said Wednesday. The new 40-inch monitor, model 40HT513D, features a curved IPS black panel with a 21:9 aspect ratio and 5,120-by-2,160 resolution, totaling 11 megapixels —…
LG Electronics has introduced a new diagnostic monitor cleared by the FDA for use in medical facilities, broadening its range of business-to-business displays. The 40-inch model, designated 40HT513D, boasts a curved IPS black panel with a 21:9 aspect ratio and a high 5,120-by-2,160 resolution, equating to 11 megapixels. LG claims this resolution level can replace the functionality of three earlier 3-megapixel monitors combined.
The monitor's standout feature is its three-picture-by-picture function, which divides the screen into three sections to simultaneously display distinct image sources. This setup eliminates discernible seams between adjacent monitors, a common issue that can hinder the readability of medical images, as well as the need to alternate focus between separate screens.
In the context of image-based diagnoses, clinicians typically need to compare original and prior scans from X-rays, CT, or MRI machines alongside a patient's electronic medical records. The ability to view all these elements on a single screen without the need to switch between displays significantly streamlines this process.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
